October Pharma results, Fiscal year 2020
Net profit, assets, equity and cash flow for Fiscal year 2020, against the same period a year earlier, from the published financial statements.
Net profit88.26 millionEGP
Total assets606 millionEGP
Shareholders' equity254 millionEGP
Operating cash flow21.39 millionEGP
In short
- October Pharma's net profit for Fiscal year 2020 was about 88.26 million EGP.
- Total assets at the end of Fiscal year 2020 were about 606 million EGP, and shareholders' equity about 254 million EGP.
- Operating cash flow for Fiscal year 2020 was positive at 21.39 million EGP.
Key lines against the same period a year earlier
This periodYear earlierChange
Net profit88.26 million——
Gross profit261 million——
Total assets606 million——
Total liabilities352 million——
Shareholders' equity254 million——
Total liabilities and equity606 million——
Operating cash flow21.39 million——
Investing cash flow-6.98 million——
Financing cash flow-29.28 million——
Net change in cash-14.86 million——
Figures in EGP from the published statement summaries (consolidated where the company publishes consolidated statements), after normalising reporting units across periods. The exact figure is in the attached report, which may be the standalone version.
October Pharma's Q3 2026 results, the day they are published
One email on the day, no account, and a one-click stop in the email itself.
By subscribing you agree to receive these alerts only. Privacy policy